Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Cancer · Hepatocellular Cancer · Biliary Tract Cancer · Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cross Cancer Institute, Edmonton, Alberta, Canada
Contact: Study coordinator (Jennifer Spratlin, MD FRCPC) · Jennifer.Spratlin@albertahealthservices.ca · 7804328290

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

Biliary Tract Cancer (BTC) · Biliary Tract Cancer (CCA) · Cholangiocarcinoma

Abroad (travel likely)Recruiting

Nottingham, United Kingdom

AB122 Platform Study

Advanced or Metastatic Solid Tumor · Pancreatic Ductal Adenocarcinoma · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1

Aichi, Japan · Chiba, Japan

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

Colorectal Cancer · Cholangiocarcinoma · Appendiceal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States · Irvine, United States

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

Solid Tumor, Adult · Pancreatic Cancer · Virus-associated Tumors

Abroad (travel likely)RecruitingPHASE2

Bordeaux, France · Brest, France